Dolby Laboratories Inc (DLB) surpasses revenue and earnings expectations, raises annual guidance, and strengthens its market position with key partnerships and innovations.

Detailed price information for Dolby Laboratories (DLB-N) from The Globe and Mail including charting and trades.

Shares of Dolby Laboratories (DLB) have gained 1% over the past four weeks to close the last trading session at $64.19, but ...

For Dolby Laboratories (NYSE:DLB), the announced schedule places the ex-dividend session in early February and the ...

Dolby Laboratories, Inc. ( DLB) Q1 2026 Earnings Call January 29, 2026 5:00 PM EST Ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories conference call discussing first ...

Dolby (DLB) stock has sold off with software—read why its licensing model, high margins, and added patents boost value, plus key AI risks.

Dolby Laboratories, Inc. DLB reported first-quarter fiscal 2026 non-GAAP earnings per share (EPS) of $1.06, surpassing the ...

Dolby Laboratories (DLB) reported $346.71 million in revenue for the quarter ended December 2025, representing a year-over-year decline of 2.9%. EPS of $1.06 for the same period compares to $1.14 a ...

What is dementia with Lewy bodies? Dementia is caused by different diseases that affect the brain. Lewy body dementia is caused by Lewy body disease. In this disease, tiny clumps of proteins known as ...